{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:47:40Z","timestamp":1775486860984,"version":"3.50.1"},"reference-count":141,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Applied Sciences"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD), a slowly progressive neurodegenerative disorder, is the main cause of dementia worldwide. However, currently, the approved drugs to combat AD are effective only in treating its symptoms. In fact, an efficacious treatment for this complex and multifactorial disorder remains to be discovered, demanding the urgent development of new therapeutic approaches for the disease, such as the use of bioactive secondary metabolites (SMs) from natural sources. Sessile organisms, like plants, are unable to escape from adverse environmental conditions and must therefore create their own defense. Their main defense strategy is chemical defense that includes the production of an enormously diverse array of bioactive SMs, such as terpenes and their derivatives. This largest and most diverse group of plant SMs also provide the treatment of several diseases due to their broad-spectrum bioactivities, for example, anticancer, antioxidant, and anti-inflammatory properties. Thus, the evaluation of the neuroprotective potential of terpenes is imperative. It is known that the major AD clinical indications (CIs) are extracellular senile plaques of amyloid-\u03b2 (A\u03b2) protein, intracellular hyperphosphorylated tau (\u03c4) neurofibrillary tangles (NFTs), uncommon neuroinflammatory response, oxidative stress, and synaptic and neuronal dysfunction. Therefore, terpenes that may decrease these CIs might be used for AD treatment. Surely, terpenes targeting more than one AD pathogenic mechanism, multi-target drug ligands (MTDLs), have the potential to become a leading AD treatment. Thus, this review analyzes, for each CI, the scaffolds of the selected terpenes leading to the highest activity.<\/jats:p>","DOI":"10.3390\/app14093898","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T07:04:14Z","timestamp":1714633454000},"page":"3898","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Terpenes as Potential Anti-Alzheimer\u2019s Disease Agents"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6736-8729","authenticated-orcid":false,"given":"Elisabete","family":"Lima","sequence":"first","affiliation":[{"name":"Institute of Agricultural and Environmental Research and Technology (IITAA), University of the Azores, 9700-042 Angra do Hero\u00edsmo, Portugal"},{"name":"Department of Physics, Chemistry and Engineering (DCFQE), Faculty of Science and Technology, University of the Azores, 9500-321 Ponta Delgada, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-5881","authenticated-orcid":false,"given":"Jorge","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Physics, Chemistry and Engineering (DCFQE), Faculty of Science and Technology, University of the Azores, 9500-321 Ponta Delgada, Portugal"},{"name":"Biotechnology Centre of Azores (CBA), University of the Azores, 9700-042 Angra do Hero\u00edsmo, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","article-title":"Neuroinflammation pathways: A general review","volume":"127","author":"Shabab","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association (2019). Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement., 15, 321\u2013387.","DOI":"10.1016\/j.jalz.2019.01.010"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2147\/CIA.S11718","article-title":"Late onset Alzheimer\u2019s diseasae in older people","volume":"5","author":"Isik","year":"2010","journal-title":"Clin. Interv. Aging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/gim.2015.117","article-title":"The genetic landscape of Alzheimer disease: Clinical implications and perspectives","volume":"18","author":"Sleegers","year":"2016","journal-title":"Genet. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.plipres.2010.09.001","article-title":"Apolipoprotein E: From lipid transport to neurobiology","volume":"50","author":"Hauser","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apoliprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Ver. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apoliprotein E in Alzheimer\u2019s disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE\u03b54 markedly exacerbates tau-mediated neurodegeneration in a mouse mode tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer\u2019s disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Martins, M., Silva, R., Pinto, M.M.M., and Sousa, E. (2020). Marine natural products, multitarget therapy and repurposed agents in Alzheimer\u2019s disease. Pharmaceuticals, 13.","DOI":"10.3390\/ph13090242"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bmc.2011.12.042","article-title":"A review on coumarins as acetylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"20","author":"Anand","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ebiom.2015.01.002","article-title":"Recent advances from the bench toward the bedside in Alzheimer\u2019s disease","volume":"2","author":"Macauley","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2174\/156720510793611600","article-title":"Tau aggregation is a therapeutic target for Alzheimer\u2019s disease","volume":"7","author":"Takashima","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijge.2016.07.003","article-title":"New therapeutic targets in Alzheimer\u2019s disease","volume":"11","author":"Coman","year":"2017","journal-title":"Int. J. Gerontol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment combinatoirs for Alzheimer\u2019s disease: Current and future pharmacotherapy options","volume":"67","author":"Cummings","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bmcl.2018.11.034","article-title":"New approaches for the treatment of Alzheimer\u2019s disease","volume":"29","author":"Fish","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.cellbio.13.1.83","article-title":"Microtubule polymerization dynamics","volume":"13","author":"Desai","year":"1997","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/312237a0","article-title":"Dynamic instability of microtubule growth","volume":"312","author":"Mitchison","year":"1984","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1021\/jm301079z","article-title":"Microtubule stabilizing agents as potential treatment for Alzheimer\u2019s disease and related neurodegenerative tauopathies","volume":"55","author":"Ballatore","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"White, J.A., Banerjee, R., and Gunawardena, S. (2016). Axonal transport and neurodegeneration: How marine drugs can be used for the development of therapeutics. Mar. Drugs, 14.","DOI":"10.3390\/md14050102"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease","volume":"83","author":"Kosik","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","first-page":"151979","article-title":"Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies?","volume":"2015","author":"Naini","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_24","first-page":"731526","article-title":"Structure and pathology of tau protein in Alzheimer disease","volume":"2012","author":"Kolarova","year":"2012","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: Involvement in Alzheimer\u2019s disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer\u2019s disease: Strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15938","DOI":"10.1074\/jbc.M314116200","article-title":"Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Llorach-Pares, L., Nonell-Canals, A., Avila, C., and Sanchez-Martinez, M. (2018). Kororamides, convolutamines, and indole derivatives as possible tau and dual-specifity kinase inhibitors for Alzheimer\u2019s disease: A computational study. Mar. Drugs, 16.","DOI":"10.3390\/md16100386"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2174\/1389450115666140226112321","article-title":"Human CDC2-like kinase 1 (CLK1): A novel target for Alzheimer\u2019s disease","volume":"15","author":"Jain","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fncel.2013.00189","article-title":"Recent developments of protein kinase inhibitors as potential AD therapeutics","volume":"7","author":"Tell","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"ref_31","first-page":"595","article-title":"The role of tau kinases in Alzheimer\u2019s disease","volume":"13","author":"Dolan","year":"2010","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4155\/fmc-2016-0013","article-title":"DYRKlA inhibition as potential treatment for Alzheimer\u2019s disease","volume":"8","author":"Stotani","year":"2016","journal-title":"Future Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/acel.12648","article-title":"Dyrkl inhibition improves Alzheimer\u2019s disease-like pathology","volume":"16","author":"Branca","year":"2017","journal-title":"Aging Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_35","first-page":"46","article-title":"GSK-3, a pivotal kinase in Alzheimer disease","volume":"7","author":"Jurado","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.expneurol.2009.09.011","article-title":"GSK3: A possible link between beta amyloid peptide and tau protein","volume":"223","author":"Lucas","year":"2010","journal-title":"Exp. Neurol."},{"key":"ref_37","first-page":"S141","article-title":"GSK3 and tau: Two convergence points in Alzheimer\u2019s disease","volume":"33","author":"Lucas","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. lmmunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11910-017-0733-2","article-title":"Neuroinflammation in neurodegenerative disorders: A review","volume":"17","author":"Schain","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Barbalace, M.C., Malaguti, M., Giusti, L., Lucacchini, A., Hrelia, S., and Angeloni, C. (2019). Anti-inflammatory activities of marine algae in neurodegenerative diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20123061"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease","volume":"23","author":"Salter","year":"2017","journal-title":"Nat. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.3389\/fimmu.2018.02576","article-title":"Microglia: Immune regulators of neurodevelopment","volume":"9","author":"Cowan","year":"2018","journal-title":"Front. Lmmunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Dong, Y., Li, X., Cheng, J., and Hou, L. (2019). Drug development for Alzheimer\u2019s disease: Microglia induced neuroinflammation as a target?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030558"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fncel.2019.00514","article-title":"Pharmacological targeting of microglial activation: New therapeutic approach","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0896-6273(94)90331-X","article-title":"Acetylcholinesterase density and turnover number at frog neuromuscular\u2013junctions, with modeling of their role in synaptic function","volume":"12","author":"Anglister","year":"1994","journal-title":"Neuron"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: Targeting the cholinergic system","volume":"14","author":"Guimaraes","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1039\/b508966m","article-title":"Acetylcholinesterase inhibitors from plants and fungi","volume":"23","author":"Houghton","year":"2006","journal-title":"J. Nat. Prod. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-\u03b2-peptides into Alzheimer\u2019s fibrils: Possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1523\/JNEUROSCI.18-09-03213.1998","article-title":"Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer\u2019s fibrils","volume":"18","author":"Alvarez","year":"1998","journal-title":"J. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/iub.1386","article-title":"Endoplasmic reticulum quality control and systemic amyloid disease: Impacting protein stability from the inside out","volume":"67","author":"Chen","year":"2015","journal-title":"IUBMB Life"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejmech.2019.02.076","article-title":"Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer\u2019s disease","volume":"169","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5487\/TR.2017.33.2.097","article-title":"Terpenes from forests and human health","volume":"33","author":"Cho","year":"2017","journal-title":"Toxicol. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/aps.2010.46","article-title":"Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia","volume":"31","author":"Wang","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"704197","DOI":"10.3389\/fphar.2021.704197","article-title":"Therapeutic applications of terpenes on inflammatory diseases","volume":"12","author":"Sergio","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1039\/b820413f","article-title":"Meroterpenoids produced by fungi","volume":"26","author":"Geris","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ninkuu, V., Zhang, L., Yan, J., Fu, Z., Yang, T., and Zeng, H. (2021). Biochemistry of terpenes and recent advances in plant protection. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115710"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Bodor, N., and Buchwald, P. (2012). Retrometabolic Drug Design and Targeting, John Wiley & Sons.","DOI":"10.1002\/9781118407738"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"11","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1471-4159.2003.01652.x","article-title":"Interaction between flavonoids and the blood-brain barrier: In vitro studies","volume":"85","author":"Youdim","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.lfs.2018.07.036","article-title":"Exploring the potential of marine microbes in clinical management of Alzheimer\u2019s disease: A road map for bioprospecting and identifying promising isolates","volume":"208","author":"Muralidharan","year":"2018","journal-title":"Life Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ffj.3156","article-title":"A necrodane monoterpenoid from Lavandula luisieri essential oil as a cell-permeable inhibitor of BACE-1, the \u03b2-secretase in Alzheimer\u2019s disease","volume":"28","author":"Videira","year":"2013","journal-title":"Flavour Fragr. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1055\/a-1019-9819","article-title":"Natural compounds with anti-BACE1 as promising therapeutic drugs for treating Alzheimer\u2019s disease","volume":"85","author":"Naushad","year":"2019","journal-title":"Planta Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuropharm.2015.02.015","article-title":"Gracilins: Sponginella-derived promising compounds for Alzheimer\u2019s didease","volume":"93","author":"Alonso","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/10286020902843152","article-title":"Ginsenoside Rg1 inhibits \u03b2-secretase activity in vitro and protects against A\u03b2-induced cytotoxicity in PC12 cells","volume":"11","author":"Wang","year":"2009","journal-title":"J. Asian Nat. Prod. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2016.11.006","article-title":"Ginsenoside Re reduces A\u03b2 production by activating PPAR\u03b3 to inhibit BACE1 in N2a\/APP695 cells","volume":"793","author":"Cao","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1096\/fj.05-5530fje","article-title":"Reductions in levels of the Alzheimer\u2019s amyloid \u03b2 peptide after oral administration of ginsenosides","volume":"20","author":"Chen","year":"2006","journal-title":"FASEB J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"154485","DOI":"10.1016\/j.phymed.2022.154485","article-title":"Evaluating Cannabis sativa L.\u2019s neuroprotection potential: From bench to bedside","volume":"107","author":"Laws","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.phrs.2018.10.024","article-title":"Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer\u2019s disease-type pathologies in SAMP8 mice","volume":"139","author":"Zhen","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1021\/cr0503097","article-title":"Assembly-line enzymologty for polyketide and nonribosomal peptide antibiotics: Logic, machinery, and mechanisms","volume":"106","author":"Fischbach","year":"2006","journal-title":"Chem. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nchem.764","article-title":"Reconstitution of a fungal meroterpenoid biosynthesis reveals the involvement of a novel family of terpene cyclases","volume":"2","author":"Itoh","year":"2010","journal-title":"Nat. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1039\/C6SC02464E","article-title":"Asperterpenes A and B, two unprecedented meroterpenoids from Aspergillus terreus with BACE1 inhibitory activities","volume":"7","author":"Qi","year":"2016","journal-title":"Chem. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1021\/acs.jnatprod.7b01050","article-title":"BACE1 Inhibitory meroterpenoids from Aspergillus terreus","volume":"81","author":"Qi","year":"2018","journal-title":"J. Nat. Prod."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"9046","DOI":"10.1039\/C8OB02741B","article-title":"New 3,5-dimethylorsellinic acid-based meroterpenoids with BACE1 and AchE inhibitory activities from Aspergillus terreus","volume":"16","author":"Qi","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.bmc.2015.04.080","article-title":"Isolation of cholinesterase and \u03b2-secretase 1 inhibiting compounds from Lycopodiella cernua","volume":"23","author":"Nguyen","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1248\/bpb.b19-00495","article-title":"Neuroprotective effects of limonene (+) against A\u03b242-induced neurotoxicity in a Drosophila Model of Alzheimer\u2019s Disease","volume":"43","author":"Shin","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Fakhri, S., Pesce, M., Patruno, A., Moradi, S.Z., Iranpanah, A., Farzaei, M.H., and Sobarzo-Sanchez, E. (2020). Attenuation of NrF2\/Keap1\/ARE in Alzheimer\u2019s disease by plant secondary metabolites: A mechanistic review. Molecules, 25.","DOI":"10.3390\/molecules25214926"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8887716","DOI":"10.1155\/2021\/8887716","article-title":"Linalool alleviates A\u03b242-Induced neurodegeneration via suppressing ROS production and inflammation in fly and rat models of Alzheimer\u2019s disease","volume":"2021","author":"Yuan","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/med.21842","article-title":"The immunosuppressive activity of artemisin-type drugs towards inflammatory and auto immune diseases","volume":"41","author":"Efferth","year":"2021","journal-title":"Med. Res. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/0960327118755256","article-title":"Thymoquinone alleviates the experimentally induced Alzheimer\u2019s disease inflammatory by modulation of TLRs signaling","volume":"37","author":"Abulfadl","year":"2018","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11010-019-03622-8","article-title":"Cytotoxic and antiproliferative effects of thymoquinone on rat C6 glioma cells depend on oxidative stress","volume":"462","author":"Krylova","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4079425","DOI":"10.1155\/2017\/4079425","article-title":"The neuroprotective effects of ethanol-induced hippocampal neurons impairment via the antioxidative and antipoptotic pathways","volume":"2017","author":"Wang","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1515\/znc-2014-4135","article-title":"In vitro neuroprotective potential of the monoterpenes \u03b1-pinene and 1,8-cineole against H2O2-induced oxidative stress in PC12 cells","volume":"71","author":"Carretero","year":"2016","journal-title":"Z. Naturforsch. C J. Biosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/13880209.2014.923003","article-title":"Evaluation of p-cymene, a natural antioxidante","volume":"53","author":"Oliveira","year":"2015","journal-title":"Pharm. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11064-014-1267-5","article-title":"Is there a correlation between in vitro antioxidant potential and in vivo effect of carvacryl acetate against oxidative stress in mice hippocampus?","volume":"39","author":"Pires","year":"2014","journal-title":"Neurochem. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/13880209.2012.700718","article-title":"Borneol alleviates oxidative stress via upregulationof Nrf2 and Bcl-2 in SH-SY5Y cells","volume":"51","author":"Hur","year":"2013","journal-title":"Pharm. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"10","DOI":"10.22159\/ajpcr.2017.v10i7.18564","article-title":"Analysis of the antioxidant activity of geraniol employing various in vitro models. Relevance to neurodegeneration in diabetic neuropathy","volume":"10","author":"Prasad","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s10787-020-00751-1","article-title":"Alzheimer\u2019s disease: Natural products as inhibitors of neuroinflammation","volume":"28","author":"Olajide","year":"2020","journal-title":"Inflammopharmacalogy"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1135\/cccc19610803","article-title":"On terpenes CXVIII. Constitution of parthenolide","volume":"26","author":"Herout","year":"1961","journal-title":"Collect. Czech. Chem. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.redox.2018.05.015","article-title":"Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara","volume":"18","author":"Lee","year":"2018","journal-title":"Redox Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuint.2016.06.010","article-title":"Lactucopicrin ameliorates oxidative stress mediated by scopolamineinduced neurotoxicity through activation of the NRF2 pathway","volume":"99","author":"Subedi","year":"2016","journal-title":"Neurochem. Int."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1039\/C8FO00057C","article-title":"\u03b1-Cyperone inhibits LPS-induced inflammation in BV-2 cells through activation of Akt\/Nrf2\/HO-1 and suppression of the NF-\u03baB pathway","volume":"9","author":"Huang","year":"2018","journal-title":"Food Funct."},{"key":"ref_94","first-page":"1683","article-title":"Petasites japonicus bakkenolide B inhibits lipopolysaccharide-induced pro-inflammatory cytokines via AMPK\/Nrf2 induction in microglia","volume":"41","author":"Park","year":"2018","journal-title":"Int. J. Molec. Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Deng, M., Yan, W., Gu, Z., Li, Y., Chen, L., and He, B. (2023). Anti-neuroinflammatory potential of natural products in the treatment of Alzheimer\u2019s disease. Molecules, 28.","DOI":"10.3390\/molecules28031486"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Satoh, T., Trudler, D., Oh, C.K., and Lipton, S.A. (2022). Potential therapeutic use of the Rosemary diterpene carnosic acid for Alzheimer\u2019s disease, Parkinson\u2019s disease, and long-COVID through NRF2 activation to counteract the NLRP3 inflammasome. Antioxidants, 11.","DOI":"10.3390\/antiox11010124"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"17792","DOI":"10.1021\/jacs.2c08351","article-title":"Total synthesis of ginkgolide C and formal synthesis of ginkgolides A and B","volume":"144","author":"Hebert","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1039\/D1NP00026H","article-title":"Structure, synthesis, biosynthesis, and activity of the characteristic compounds from Ginkgo biloba L","volume":"39","author":"Liu","year":"2022","journal-title":"Nat. Prod. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1007\/s12010-022-03828-5","article-title":"Protective effects of ginkgolide on a cellular model of Alzheimer\u2019s disease via suppression of the NF-kappaB signaling pathway","volume":"194","author":"Niu","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Lv, Z., Yang, Y., Wang, J., Chen, J., Li, J., and Di, L. (2018). Optimization of the preparation conditions of borneol-modified ginkgolide liposomes by response surface methodology and study of their blood brain barrier permeability. Molecules, 23.","DOI":"10.3390\/molecules23020303"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/md12020700","article-title":"Spongionella secondary matabolites protect mitochondrial function in cortical neurons against oxidative stress","volume":"12","author":"Alonso","year":"2014","journal-title":"Mar. Drugs"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4062\/biomolther.2013.053","article-title":"Ginsenoside Rg3 alleviates lipopolysacaharide-induced learning and memory impairments by anti-inflammatory activity in rats","volume":"21","author":"Lee","year":"2013","journal-title":"Biomol. Ther."},{"key":"ref_103","first-page":"185","article-title":"A therapeutic intervention for Alzheimer\u2019s disease using ginsenoside Rg3: Its role in M2 microgial activation and non-amyloidogenesis","volume":"72","author":"Ahn","year":"2021","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"688490","DOI":"10.3389\/fphar.2021.688490","article-title":"Neuroprotective potentials of Panax Ginseng against Alzheimer\u2019s disease: A review of preclinical and clinical evidences","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Liu, M., Bai, X., Yu, S., Zhao, W., Qiao, J., Liu, Y., Zhao, D., Wang, J., and Wang, S. (2019). Ginsenoside Re inhibits ROS\/ASK-1 dependent mitochondrial apoptosis pathway and activation of Nrf2-antioxidant response in beta-amyloid-challenged SH-SY5Y cells. Molecules, 24.","DOI":"10.3390\/molecules24152687"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pbb.2014.02.012","article-title":"Protective effects of ginsenoside Rg1 on chronic restraint stress induced learning and memory impairments in male mice","volume":"120","author":"Wang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbagen.2014.11.021","article-title":"Nrf2 regulates ROS production by mitochondria and NADPH oxidase","volume":"1850","author":"Kovac","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Du, J., Cui, C.-H., Park, S.C., Kim, J.-K., Yu, H.-S., Jin, F.-X., Sun, C., Kim, S.-C., and Im, W.-T. (2014). Identification and characterization of a ginsenoside-transforming \u03b2-glucosidase from Pseudonocardia sp. Gsoil 1536 and its application for enhanced production of minor ginsenoside Rg2(S). PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096914"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/ptr.6044","article-title":"Neuroprotective effects of 20(S)-protopanaxatriol (PPT) on scopolamine-induced cognitive deficits in mice","volume":"32","author":"Lu","year":"2018","journal-title":"Phytother. Res."},{"key":"ref_110","first-page":"S516","article-title":"Consumer acceptance of ginseng food products","volume":"76","author":"Hung","year":"2011","journal-title":"J. Food Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.taap.2014.03.026","article-title":"Attenuation of A\u03b225\u201335-induced parallel autophagic and apoptotic cell death by gypenoside XVII through the estrogen receptor-dependent activation of Nrf2\/ARE pathways","volume":"279","author":"Meng","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cbdv.201400190","article-title":"Cytotoxic and nitric oxide production-inhibitory activities of limonoids and other compounds from the leaves and bark of Melia azedarach","volume":"11","author":"Pan","year":"2014","journal-title":"Chem. Biodiv."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.fitote.2017.04.011","article-title":"Triterpenoids and iridoids from Patrinia scabiosaefolia","volume":"119","author":"Liu","year":"2017","journal-title":"Fitoterapia"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Min, S.L.S., Liew, S.Y., Chear, N.J.Y., Goh, B.H., Tan, W.-N., and Khaw, K.Y. (2022). Plant terpenoids as the promising source of cholinesterase inhibitors for anti-AD therapy. Biology, 11.","DOI":"10.3390\/biology11020307"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Dzoyem, J.P., Tsamo, A.T., Melong, R., Mkounga, P., Nkengfack, A.E., McGaw, L.J., and Elof, J.N. (2015). Cytotoxicity, nitric oxide and acetylcholinesterase inhibitory activity of three limonoids isolated from Trichilia welwitschii (Meliaceae). Biol. Res., 48.","DOI":"10.1186\/s40659-015-0049-0"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1021\/np5003687","article-title":"Weakly Anti-inflammatory limonoids from the seeds of Xylocarpus rumphii","volume":"77","author":"Sarigaputi","year":"2014","journal-title":"J. Nat. Prod."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"7851","DOI":"10.1007\/s12035-019-1636-9","article-title":"Gedunin inhibits oligomeric A\u03b21\u201342-induced microglia activation via modulation of Nrf2-NF-\u03baB signaling","volume":"56","author":"Tom","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jnutbio.2018.01.009","article-title":"Supplementation of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress","volume":"56","author":"Wang","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Fakhri, S., Aneva, I.Y., Farzaei, M.H., and Sobarzo-S\u00e1nchez, E. (2019). The neuroprotective effects of astaxanthin: Therapeutic targets and clinical perspective. Molecules, 24.","DOI":"10.3390\/molecules24142640"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2018.08.012","article-title":"Astaxanthin: A mechanistic review on its biological activities and health benefits","volume":"136","author":"Fakhri","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1515\/chem-2017-0040","article-title":"Volatile terpenoids as potential drug leads in Alzheimer\u2019s disease","volume":"15","author":"Klimek","year":"2017","journal-title":"Open Chem."},{"key":"ref_122","first-page":"138","article-title":"Sesquiterpene lactones from Cynara cornigera: Acetyl cholinesterase inhibition and in silico ligand docking","volume":"82","author":"Hegazy","year":"2016","journal-title":"Planta Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1021\/acs.jafc.5b04168","article-title":"Dihydroagarofuranoid sesquiterpenes as acetylcholinesterase inhibitors from Celastraceae plants: Maytenus disticha and Euonymus japonicus","volume":"63","author":"Cespedes","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Afifa Zardi-Bergaoui, A., Znati, M., Harzallah-Skhiri, F., and Jannet, H.B. (2019). Caryophyllene Sesquiterpenes from Pulicaria vulgaris Gaertn.: Isolation, structure determination, bioactivity and structure. Chem. Biodivers., 16.","DOI":"10.1002\/cbdv.201800483"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1186\/s40064-016-3199-9","article-title":"Anti-inflammatory and acetylcholinesterase activity of extract, fractions, and five compounds isolated from the leaves and twigs of Artemisia annua growing in Cameroon","volume":"5","author":"Chougouo","year":"2016","journal-title":"Springerplus"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.fitote.2016.05.014","article-title":"Five new 5,11-epoxyguaiane sesquiterpenes in agarwood \u201cQi-Nan\u201d from Aquilaria sinensis","volume":"112","author":"Yang","year":"2016","journal-title":"Fitoterapia"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"104366","DOI":"10.1016\/j.fitote.2019.104366","article-title":"Anti-cholinesterase activities of constituents isolated from Lycopodiastrum casuarinoides","volume":"139","author":"Liu","year":"2019","journal-title":"Fitoterapia"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11418-015-0908-6","article-title":"Cholinesterase-inhibitory diterpenoids and chemical constituents from aerial parts of Caryopteris mongolica","volume":"69","author":"Murata","year":"2015","journal-title":"J. Nat. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.phytochem.2016.10.012","article-title":"Selective in vitro and in silico butyrylcholinesterase inhibitory activity of diterpenes and rosmarinic acid isolated from Perovskia atriplicifolia Benth. and Salvia glutinosa L","volume":"133","author":"Senol","year":"2017","journal-title":"Phytochemistry"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Dash, U.C., Kanhar, S., Dixit, A., Dandapat, J., and Sahoo, A.K. (2019). Isolation, identification, and quantification of pentylcurcumene from Geophila repens: A new class of cholinesterase inhibitor for Alzheimer\u2019s disease. Bioorg. Chem., 88.","DOI":"10.1016\/j.bioorg.2019.102947"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1021\/acs.jnatprod.8b00461","article-title":"Colocynthenins A\u2212D, ring-A seco-cucurbitane triterpenoids from the fruits of Citrullus colocynthis","volume":"81","author":"Liu","year":"2018","journal-title":"J. Nat. Prod."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1080\/10286020.2017.1367770","article-title":"Chemical characteristics of the fungus Ganoderma lucidum and their inhibitory effects on acetylcholinesterase","volume":"20","author":"Wei","year":"2018","journal-title":"J. Asian Natural Products Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/ol4003702","article-title":"Norfriedelins A-C with acetylcholinesterase inhibitory activity from acerola tree (Malpighia emarginata)","volume":"15","author":"Liu","year":"2013","journal-title":"Org. Lett."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1080\/14786419.2019.1679138","article-title":"Acetylcholinesterase and \u03b1-glucosidase inhibitory compounds from Callicarpa maingayi","volume":"35","author":"Ado","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/14756366.2014.895720","article-title":"Cholinesterase inhibitory triterpenoids from the bark of Garcinia hombroniana","volume":"30","author":"Jamila","year":"2015","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Li, H., Sun, W., Deng, M., Qi, C., Chen, C., Zhu, H., Luo, Z., Wang, J., Xue, Y., and Zhang, Y. (2018). Aperversins A and B, two novel meroterpenoids with an unusual 5\/6\/6\/6 ring from the marine-derived fungus Aspergillus versicolor. Mar. Drugs, 16.","DOI":"10.3390\/md16060177"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodeghenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1021\/acs.jmedchem.9b00017","article-title":"Rational design of multitarget-directed ligands: Strategies and emerging paradigms","volume":"62","author":"Zhou","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"106055","DOI":"10.1016\/j.phrs.2021.106055","article-title":"Polypharmacology: The science of multi-targeting molecules","volume":"176","author":"Kabir","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Lima, E., and Medeiros, J. (2022). Marine organisms as alkaloid biosynthesizers of potential anti-Alzheimer agents. Mar. Drugs, 20.","DOI":"10.3390\/md20010075"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1039\/C4MD00069B","article-title":"Two disease, one approach: Multitarget drug discovery in Alzheimer\u2019s and neglected tropical diseases","volume":"5","author":"Prati","year":"2014","journal-title":"Med. Chem. Comm."}],"container-title":["Applied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3417\/14\/9\/3898\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:38:49Z","timestamp":1760107129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3417\/14\/9\/3898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":141,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["app14093898"],"URL":"https:\/\/doi.org\/10.3390\/app14093898","relation":{},"ISSN":["2076-3417"],"issn-type":[{"value":"2076-3417","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}